NCT07334678 TROPIS Versus Coring Out Fistulectomy in High Anal Fistula
| NCT ID | NCT07334678 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | High Anal Fistula |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-07-08 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-07-08 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
High anal fistulas represent a surgical challenge due to high recurrence rates and risk of postoperative fecal incontinence. Several sphincter-preserving techniques have been developed to address these issues. Coring Out fistulectomy is a traditional sphincter-saving approach, while Transanal Opening of the Intersphincteric Space (TROPIS) is a recently introduced technique with promising outcomes. This randomized clinical trial aims to compare the efficacy, safety, and patient outcomes of TROPIS versus coring out fistulectomy in the management of high complex anal fistulas.
Eligibility Criteria
Inclusion Criteria: * Patients with high anal fistula ( involving more than 1/3 of the sphincter complex), whether de novo or recurrent Exclusion Criteria: * Patients with fistula secondary to malignancy, inflammatory bowel disease, trauma or radiation * Patients with Low anal fistula * Patient with preoperative fecal incontinence * Previous levator ani muscle injury
Contact & Investigator
Haitham M.Azmy Basiouny, Lecturer
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT07334678 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying High Anal Fistula. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07334678 currently recruiting?
Yes, NCT07334678 is actively recruiting participants. Contact the research team at drabdelaal90@gmail.com for enrollment information.
Where is the NCT07334678 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07334678 clinical trial?
NCT07334678 is sponsored by Cairo University. The principal investigator is Haitham M.Azmy Basiouny, Lecturer at Cairo University. The trial plans to enroll 64 participants.